Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
21.74
+0.92 (4.42%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $598.18 million as of October 9, 2026. It is the 13,613th most valuable company in the world and the 2,630th biggest in the United States. Its market cap has decreased by 14.40% in one year.
Market Cap
598.18M
Enterprise Value
56.44M
1-Year Change
-14.40%
Global Rank
Country Rank
#2,630 United States
Category
ChartMarket Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $598.18M, an increase of 282.23%. That is a compound annual growth rate of 14.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 598.20M | -26.34% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 2.10B |
| GeneDx Holdings | 2.01B |
| Personalis | 1.71B |
| Freenome | 1.70B |
| Castle Biosciences | 1.05B |
| OPKO Health | 1.03B |
| Myriad Genetics | 412.25M |
| Biodesix | 274.54M |